A weight-loss medication that was recently licensed for use on the NHS has been connected to the death of a Scottish nurse.
Susan McGowan, 58, died on September 4th of this year from pancreatitis, septic shock, and multiple organ failure, all of which were recorded as her direct causes of death.
The usage of “prescribed tirzepatide,” an injectable that aids in weight loss, was noted as a significant factor as well.
According to the BBC, it is believed to be the first fatality in the UK to be formally connected to a medication made by the pharmaceutical company Eli Lilly.
The UK’s drugs watchdog last year authorized the medication, which was created for individuals with type 2 diabetes, for use on the NHS.
